The TPI1 gene gives your cells instructions for an enzyme that helps turn sugar into usable energy. If this gene does not work properly, cells with high energy needs, especially red blood cells, muscles, and the brain, may struggle, which can lead to a rare inherited condition called TPI1 deficiency. People with this condition may have ongoing anemia, muscle weakness, movement problems, developmental delay, or repeated infections. Most people hear about the TPI1 gene only through genetic testing for unexplained symptoms.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do much of the work. Others mainly help control when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
TPI1Gene function
What if the gene works
The TPI1 gene makes an enzyme that helps cells turn sugar into usable energy. This step supports many tissues, especially muscles, the brain, and red blood cells.
Risk
What if the gene does not work
When the TPI1 gene does not work properly, it can cause triosephosphate isomerase deficiency, often with hemolytic anemia and nerve or muscle problems. Milder and more severe variants can affect when symptoms begin and how much of the body is affected.
Treatment
What does that mean for your treatment
No treatment or drug selection approach specific to the TPI1 gene is currently established for pathogenic variants. The TPI1 gene is being studied in cancer and cell metabolism research as a possible biomarker and drug target, but this has not yet changed routine care.
Conditions associated with TPI1
Gene function
What if the gene works
Every day, your cells break down sugar to make fuel for routine tasks. Understanding how the TPI1 gene supports energy production helps show how both halves of sugar can be used efficiently. When the TPI1 gene works properly, its protein keeps a key step moving smoothly inside many kinds of cells.
The TPI1 gene makes a protein that quickly switches one small sugar piece into another form your cells can use right away. This keeps the sugar to energy pathway moving smoothly.
After glucose is split into two small pieces, only one can move straight into the next energy making steps. Its protein converts the other piece into the same usable form, so both halves can contribute to cell fuel.
This gene helps keep two closely linked sugar molecules in balance during glycolysis (the main process cells use to break down sugar for energy). That balance supports steady energy handling and efficient use of cell fuel.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change gene function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the TPI1 gene can make its protein unstable, misshapen, or less active, so cells cannot use it well. How variants in the TPI1 gene affect function depends on the change: milder variants may leave some activity, while more disruptive variants can cause the protein to break down early or work very poorly. In people with TPI1 deficiency, this range in functional effect can influence how early symptoms begin and how severe they are.
How variants are linked to conditions
Pathogenic variants in the TPI1 gene can cause triosephosphate isomerase deficiency, a very rare inherited condition. This TPI1 gene condition is usually confirmed when a person has disease-causing variants in both copies of the gene. People with triosephosphate isomerase deficiency often have ongoing hemolytic anemia and may also develop muscle weakness, movement or developmental difficulties, and repeated infections.
A variant is not necessarily a diagnosis
Variants in genes are a normal part of being human and are common across the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant connected to a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, however, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For TPI1, risk is mainly shaped by inheritance: it is highest when both biological parents carry a harmful TPI1 variant. There is not broadly confirmed evidence that lifestyle or everyday exposures change the chance of having a TPI1-related condition. Anyone concerned about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of TPI1 variants
TPI1-related disease is inherited in an autosomal recessive pattern. In practical terms, how TPI1 gene variants are inherited usually means a child develops the condition only when they receive one disease-causing variant in the TPI1 gene from each parent. Parents who each carry one variant are often unaffected themselves, and with each pregnancy there is a 25% chance the child will have the condition, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. Sons and daughters are affected at the same rate.
What does my TPI1 result mean for my family?
For families with a harmful change in the TPI1 gene, close relatives may also carry the same gene change, even if they feel well. Brothers and sisters of an affected child may also be affected or be carriers, and parents are usually carriers. More distant relatives can sometimes carry the change too, so the result may matter beyond one person.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for TPI1 variants usually uses a blood sample or cheek swab to read the TPI1 gene and look for changes in its DNA code. This can show whether a person has two disease-causing variants, carries one variant, or has no relevant variant detected. Results are often interpreted alongside symptoms and family history.
When should I consider getting a genetic test?
Genetic testing for the TPI1 gene may be considered if someone has signs of this very rare inherited condition, such as ongoing breakdown of red blood cells with muscle weakness, movement problems, or developmental concerns. It can also help when a family member has a known TPI1 variant or diagnosis.
A genetic result is only one part of your health story
A genetic result can be helpful, but how much it reveals depends on the condition and the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how differences in genes can affect responses to medications. It examines gene drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how the body processes a drug and how strong its effects can be. This information can support more informed and more individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the TPI1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dosing, so questions about side effects, new symptoms, or how a treatment is working are best discussed with your doctor or pharmacist.
History
Triosephosphate isomerase deficiency was first recognized in the 1960s, when doctors described children with a rare inherited illness affecting red blood cells, muscles, and the nervous system. From these first observations, research expanded steadily. As laboratory genetics advanced in the 1970s and 1980s, scientists connected the condition to the TPI1 gene and showed that inherited variants in this gene were the cause. That work helped place TPI1 among the classic early examples of a human disease gene linked to a problem in energy metabolism. Although the condition remains rare, the TPI1 gene has had a lasting place in medical genetics because it helped researchers understand how single gene changes can affect several body systems at once.